U.S. SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 3
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934,
Section 17(a) of the Public Utility Holding Company Act of 1935 or
Section 30(f) of the Investment Company Act of 1940
--------------------------------------------------------------------------------
1. Name and Address of Reporting Person*
ORBIMED ADVISORS, LLC
--------------------------------------------------------------------------------
(Last) (First) (Middle)
767 Third Avenue, 6th Floor
--------------------------------------------------------------------------------
(Street)
New York NY 10010
--------------------------------------------------------------------------------
(City) (State) (Zip)
--------------------------------------------------------------------------------
2. Date of Event Requiring Statement (Month/Day/Year)
October 17, 2000
--------------------------------------------------------------------------------
3. IRS Identification Number of Reporting Person, if an Entity (Voluntary)
--------------------------------------------------------------------------------
4. Issuer Name and Ticker or Trading Symbol
SangStat Medical Corporation (SANG)
--------------------------------------------------------------------------------
5. Relationship of Reporting Person to Issuer
(Check all applicable)
[_] Director [X] 10% Owner
[_] Officer (give title below) [_] Other (specify below)
--------------------------------------------------------------------------------
1. Name and Address of Reporting Person*
ISALY, SAMUEL D.
--------------------------------------------------------------------------------
(Last) (First) (Middle)
767 Third Avenue, 6th Floor
--------------------------------------------------------------------------------
(Street)
New York NY 10010
--------------------------------------------------------------------------------
(City) (State) (Zip)
--------------------------------------------------------------------------------
2. Date of Event Requiring Statement (Month/Day/Year)
October 17, 2000
--------------------------------------------------------------------------------
3. IRS Identification Number of Reporting Person, if an Entity (Voluntary)
--------------------------------------------------------------------------------
4. Issuer Name and Ticker or Trading Symbol
SangStat Medical Corporation (SANG)
--------------------------------------------------------------------------------
5. Relationship of Reporting Person to Issuer
(Check all applicable)
[_] Director [X] 10% Owner
[_] Officer (give title below) [_] Other (specify below)
--------------------------------------------------------------------------------
6. If Amendment, Date of Original (Month/Day/Year)
--------------------------------------------------------------------------------
7. Individual or Joint/Group Filing (Check applicable line)
[_] Form Filed by One Reporting Person
[X] Form Filed by More than One Reporting Person
================================================================================
Table I -- Non-Derivative Securities Beneficially Owned
================================================================================
<TABLE>
<CAPTION>
3. Ownership Form:
2. Amount of Securities Direct (D) or
1. Title of Security Beneficially Owned Indirect (I) 4. Nature of Indirect Beneficial Ownership
(Instr. 4) (Instr. 4) (Instr. 5) (Instr. 4)
------------------------------------------------------------------------------------------------------------------------------------
<S> <C>
N/A--BENEFICIAL INTEREST PURSUANT TO RULE 16a-1(2).
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
====================================================================================================================================
</TABLE>
* If the Form is filed by more than one Reporting Person, see Instruction
5(b)(v).
Reminder: Report on a separate line for each class of securities beneficially
owned directly or indirectly.
================================================================================
Table II -- Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
================================================================================
<TABLE>
<CAPTION>
5. Owner-
3. Title and Amount of Securities ship
Underlying Derivative Security Form of
2. Date Exercisable (Instr. 4) Derivative
and Expiration Date --------------------------------- 4. Conver- Security:
(Month/Day/Year) Amount sion or Direct 6. Nature of
---------------------- or Exercise (D) or Indirect
Date Expira- Number Price of Indirect Beneficial
1. Title of Derivative Exer- tion of Derivative (I) Ownership
Security (Instr. 4) cisable Date Title Shares Security (Instr. 5) (Instr. 5)
------------------------------------------------------------------------------------------------------------------------------------
<S> <C>
N/A
====================================================================================================================================
</TABLE>
Explanation of Responses:
/s/Samuel D. Isaly
Managing Member of OrbiMed Advisors, LLC October 27, 2000, 2000
--------------------------------------------- -----------------------
**Signature of Reporting Person Date
** Intentional misstatements or omissions of facts constitute Federal Criminal
Violations.
See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Signature Page for Other Reporting Persons:
SAMUEL D. ISALY
By: /s/Samuel D. Isaly
----------------------
Name: Samuel D. Isaly
Designated Filer
----------------
OrbiMed Advisors, LLC Date of Event Requiring
Statement--10/17/00 Issuer Name - SANGSTAT MEDICAL
CORPORATION
Trading Symbol-"sang"
Other Reporting Persons:
------------------------
Samuel D. Isaly
767 Third Avenue, 6th Floor
New York, NY 10010
